C4 Beta Complement (C4)

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

C4 Beta Complement (C4)

Test Information:
Measurements of Complement C4 performed with this assay in human serum can be used as an aid in assessing possible complement system imbalance, associated with or observed during a number of underlying disease states or pathological conditions, including inflammatory and infectious diseases. A decrease in C4 is common, while complete absence is rare. A lowered concentration or the complete absence of C4 occurs in active immune complex diseases and autoimmune diseases, such as systemic lupus erythematosus (SLE).Infections such as bacterial and viral meningitis, streptococcal and staphylococcal sepsis and pneumonia are associated with a fall in C4.

Specimen Container:
Gold Top SST Tube (with clot activator) or Red Top Tube (Plain) – USE PLASTIC TUBE

Specimen Type:
Serum

Required Volume:
2 mL

Patient Preparation:
No Patient Preparation

Notes:
N/A (Not Applicable)

Storage & Stability
(Before Processing)

  • Storage: 4 to 8°C
    Stability: 8 days
  • Storage: 20 to 25°C
    Stability: 2 days
  • Storage: – 20°C
    Stability: 3 months

FREEZE ONLY ONCE!

Transport Temperature:
Ref (4˚C – 8˚C)

Test Category:
Routine

Test Schedule:
Daily

Results Availability:
Within 4 hours

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.